{"nct_id":"NCT01945021","title":"Phase II Safety and Efficacy Study of Crizotinib in East Asian Patients With ROS1 Positive, ALK Negative Advanced NSCLC","status":"COMPLETED","status_verified_date":"2021-02","start_date":"2013-09-30","start_date_type":"ACTUAL","primary_completion_date":"2015-07-31","primary_completion_date_type":"ACTUAL","completion_date":"2020-01-22","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["PFE"]}